Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
supplementation has demonstrated increased maximal oxygen consumption and modest weight loss in meta-analyses of overweight adults
These include: Lifestyle interventions (dietary advice, physical activity programmes) Licensed pharmacotherapy such as orlistat, or GLP-1 receptor agonists including semaglutide 2.4 mg (Wegovy, NICE TA875) or tirzepatide (Zepbound) where clinically indicated and available Referral to tier 3 or tier 4 weight management services , including bariatric surgery assessment where appropriate Information on NHS weight management services and eligibility for licensed treatments is available via the NHS website and NICE guidance
This 10 mg multi-dose vial is formulated for accuracy and stability, supporting experimental protocols related to red blood cell development, energy-metabolism pathways, and nervous-system function
Some patients may not be appropriate candidates based on active conditions, medication use, or other medical factors
US$ 22.11
US$ 21.95
US$ 22.79
US$ 28.67
